EMC
56
-7
NI
75
2
IVZ
42
2
GS
62
-10
DE
56
-2
IR
52
2
MDT
59
2
COST
50
2
MMC
53
2
L
41
4
HBAN
64
4
ILMN
49
2
LNC
48
5
MMM
52
2
AON
49
2
ROP
35
-7
KMX
63
10
AVB
54
2
XYL
49
2
HUM
37
-2
EMC
56
-7
NI
75
2
IVZ
42
2
GS
62
-10
DE
56
-2
IR
52
2
MDT
59
2
COST
50
2
MMC
53
2
L
41
4
HBAN
64
4
ILMN
49
2
LNC
48
5
MMM
52
2
AON
49
2
ROP
35
-7
KMX
63
10
AVB
54
2
XYL
49
2
HUM
37
-2
Financhill
Back

Compass Therapeutics Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
55

CMPX
Compass Therapeutics

Last Price:
$2.40
Seasonality Move:
0.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

Compass Therapeutics Stock Forecast

  • Is Compass Therapeutics Stock Undervalued?
    The current Compass Therapeutics [CMPX] share price is $2.40. The Score for CMPX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CMPX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Compass Therapeutics Stock Go Up Next Year?

Data Unavailable

Compass Therapeutics Stock Rating

Data Unavailable

Compass Therapeutics Stock Price History

Is CMPX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMPX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
compasstherapeutics.com

52-Week Data

52-Week High:
4.08
52-Week Low:
0.77

Prediction Charts

Market Cap:
331.9M
Price in USD:
2.40
Volume:
1.3M
Beta:
1.22

Technical Analysis

SMA50:
2.04
SMA100:
2.37
SMA200:
2.05
52-Wk Change:
116.22%

Stock Predictions

  • Is Compass Therapeutics stock public?
    Yes, Compass Therapeutics is a publicly traded company.
  • What is the Compass Therapeutics stock quote today?
    The Compass Therapeutics stock price is 2.40 USD today.
  • How to buy Compass Therapeutics stock online?
    You can buy Compass Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-2 2.10 2.15 2.26 2.08
Jun-3 2.15 2.14 2.25 2.12
Jun-4 2.24 2.17 2.26 2.16
Jun-5 2.18 2.36 2.36 2.12
Jun-6 2.42 2.50 2.55 2.40
Jun-9 2.54 2.57 2.74 2.49
Jun-10 2.59 2.51 2.64 2.50
Jun-11 2.54 2.43 2.55 2.42
Jun-12 2.41 2.41 2.51 2.36
Jun-13 2.39 2.41 2.43 2.28
Jun-16 2.48 2.37 2.49 2.36
Jun-17 2.38 2.19 2.47 2.17
Jun-18 2.18 2.38 2.44 2.18
Jun-20 2.44 2.40 2.44 2.29

Compass Therapeutics Earnings

Data Unavailable

Compass Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.04 per share.

* Compass Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.